redlight.store

Reviewed August 31, 2026

What the Research Says About Red Light Therapy for Hair Growth

Hair is the one part of this category where the FDA has actually looked at clinical data, where the trials use a hard countable endpoint, and where sham-controlled designs are the norm rather than the exception.

It is also the part where almost every trial was paid for by someone selling a device. Both things are true at once.

The endpoint is unusually honest

Hair trials count hairs. A defined target area on the scalp is tattooed or otherwise marked, photographed under standardized macro conditions, and the terminal hairs in that area are counted by a blinded assessor at baseline and at the end.

That is a far better endpoint than "82 percent of users agreed their skin looked brighter". It is not perfect, since counts are sensitive to how the area is clipped, lit and defined, but it is objective and it is repeatable.

The anchor trial

Lanzafame and colleagues published a double-blind, sham-controlled trial in Lasers in Surgery and Medicine in 2013. 44 men with androgenetic alopecia used either a 655nm laser and LED helmet or a visually identical sham unit over 16 weeks.

The active group showed a 39 percent increase in hair counts over the sham group. That result is the single most quoted number in the hair device market, and unlike a lot of what gets quoted in this space, it holds up on inspection.

Lanzafame ran the same protocol in women and published it in the same journal in 2014, again reporting significant increases in hair counts against sham.

The biggest trial

Jimenez and colleagues published a multicenter, randomized, sham device-controlled, double-blind study in the American Journal of Clinical Dermatology in 2014. 269 subjects, 128 men and 141 women, treated the whole scalp three times a week for 26 weeks with one of three lasercomb models or a sham device delivered in concealed packaging.

Average terminal hair count increased by over 20 hairs per square centimeter in the active groups.

269 people over 26 weeks is a serious trial by the standards of any consumer device category. It was also conducted on Lexington International's HairMax devices, which is the pattern you will see repeatedly here.

The most recent sham-controlled data

Yoon and colleagues published a 16-week, multicenter, randomized, double-blind, sham device-controlled trial in Medicine (Baltimore) in 2020 using a helmet-type device with 655nm laser diodes and LEDs, 25 minutes every other day.

59 participants completed. Hair density rose by 41.90 hairs per square centimeter in the active group against 0.72 in the sham group. Hair thickness rose 7.50 micrometers in the active group and fell 15.03 micrometers in the sham group. Both differences were significant at p < 0.001.

There is a detail in that paper worth flagging: the active device measured 2.56 mW/cm2. That is a very low irradiance, roughly one fortieth of what a mid-range panel claims. Scalp devices do not win by brute force. See why irradiance numbers are usually wrong.

What the reviews conclude

Afifi and colleagues reviewed the field in Lasers in Surgery and Medicine in 2017, covering eleven studies with wavelengths from 630 to 780nm, session lengths of 8 to 25 minutes and treatment durations from 24 weeks to 24 months. Nine of the studies assessed hair count or density and found statistically significant improvements in both men and women, with the clearest results at 655nm.

Pillai and Mysore reached a similar position in the Journal of Cutaneous and Aesthetic Surgery in 2021: a real effect in androgenetic alopecia, with a literature that is short on independent replication.

Where the evidence is weak

Sponsorship is the big one. The trials driving this market were largely funded or supplied by device manufacturers. Independent replication is rare enough that you should treat effect sizes as an upper bound.

Duration is short. Sixteen to twenty-six weeks is the norm. Androgenetic alopecia is a lifelong condition and there is very little published data on what these devices do at three years, or on how quickly gains reverse when you stop using them. The realistic assumption is that they reverse, as they do with minoxidil.

The population is narrow. Trials recruit people with early to moderate pattern loss and existing miniaturized follicles. There is no credible evidence that light regrows hair on a scalp with no viable follicles left, and none at all for scarring alopecias.

Head-to-head comparisons are thin. Nobody has run a large, long, independent trial of a laser cap against finasteride or 5 percent minoxidil with the same endpoints. The honest position is that light therapy is a plausible addition to those treatments rather than a demonstrated replacement.

And the effect, where real, is modest. A gain of 20 to 40 hairs per square centimeter in a target area is measurable. It is not the transformation implied by the before-and-after photos.

Lasers, LEDs and diode counts

The clinical evidence for hair was built on low-level laser therapy specifically. That is why serious caps quote laser diode counts and why the FDA pathway for these devices exists at all.

Read those counts carefully. When a helmet advertises 500 diodes, that figure may combine laser diodes with ordinary LEDs, and the two are not equivalent contributors. A cap with 80 or 272 genuine lasers and no LED padding is a more honest spec sheet than one with a bigger combined number.

Coverage matters as much as count. A comb that you pass over the scalp and a cap that sits on it deliver very different total energy, which is covered in panel, mask, wrap or cap.

What FDA clearance actually covers here

Hair devices are cleared, not approved. Clearance under the 510(k) pathway means the manufacturer demonstrated substantial equivalence to an already-marketed device. HairMax's PowerFlex 272, for example, is cleared under K180885 for promoting hair growth.

Those clearances are written narrowly. A typical one covers promoting hair growth in men with specific Norwood-Hamilton pattern classifications and Fitzpatrick skin types I to IV, with a separate range for women. Outside those parameters, the clearance says nothing.

It also says nothing about how well one cleared device performs against another cleared device. Every laser cap on the market carries a clearance. That fact cannot be used to separate them.

FAQ

How long before I know if it is working? Six months minimum. The published trials ran 16 to 26 weeks before measuring, and hair cycles are slow enough that anything shorter is noise. Several caps carry long return windows specifically because of this.

Does it work alongside minoxidil or finasteride? There is no reason to expect interference, and light therapy is usually positioned as an add-on rather than a substitute. The comparative data is not strong enough to tell you how much it adds on top of a drug that is already working.

Are cheaper caps with fewer diodes useless? Not necessarily. Total delivered energy across the scalp is what matters, and the trial device in Yoon 2020 ran at 2.56 mW/cm2. Check laser count, session length and scalp coverage together rather than fixating on one number.

Will it help a receding hairline or bald crown? It may support hair in areas where follicles are miniaturized but still alive. Where the scalp is genuinely bald, there is nothing in the literature to suggest light restores follicles that are gone.

Sources

Keep reading